APO Research
Talk to an analyst

APO RESEARCH · REPORT

Abortion Medication

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Abortion Medication Market Outlook and Growth Opportunities 2026

23 December 2025195 pages

Choose your research edition.

Industry ResearchAbortion Medication Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Abortion Medication Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Abortion Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Abortion Medication Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Abortion Medication Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Abortion Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Abortion Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Abortion Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Abortion Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Abortion Medication market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Abortion Medication market include Cadila, Cipla, Exelgyn Laboratories, GenBioPro, Zizhu-pharm, Shanghai Xinhualian Pharmaceutical Co., Ltd and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Abortion Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Abortion Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Abortion Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Abortion Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Abortion Medication Segment by Company

Cadila

Cipla

Exelgyn Laboratories

GenBioPro

Zizhu-pharm

Shanghai Xinhualian Pharmaceutical Co., Ltd

Sun Pharma

Abortion Medication Segment by Type

Mifepristone

Misoprostol

Abortion Medication Segment by Application

Clinic

Hospital

Others

Abortion Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Abortion Medication status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Abortion Medication market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Abortion Medication significant trends, drivers, influence factors in global and regions.

6. To analyze Abortion Medication competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Abortion Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Abortion Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Abortion Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Abortion Medication market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Abortion Medication industry.

Chapter 3: Detailed analysis of Abortion Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Abortion Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Abortion Medication in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Abortion Medication Industry Trends Table 2. Abortion Medication Industry Drivers Table 3. Abortion Medication Industry Opportunities and Challenges Table 4. Abortion Medication Industry Restraints Table 5. Global Abortion Medication Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Abortion Medication Revenue Share by Company (2021-2026) Table 7. Global Abortion Medication Sales Volume by Company (k units) & (2021-2026) Table 8. Global Abortion Medication Sales Volume Share by Company (2021-2026) Table 9. Global Abortion Medication Average Price (USD/unit) of Company (2021-2026) Table 10. Global Abortion Medication Company Ranking, (2024-2026) & (USD Million) Table 11. Global Abortion Medication Key Company Manufacturing Base & Headquarters Table 12. Global Abortion Medication Company, Product Type & Application Table 13. Global Abortion Medication Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Abortion Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Mifepristone Table 18. Significant Companies of Misoprostol Table 19. Global Abortion Medication Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Abortion Medication Sales Volume by Type (2021-2026) & (k units) Table 21. Global Abortion Medication Sales Volume by Type (2027-2032) & (k units) Table 22. Global Abortion Medication Sales Volume Share by Type (2021-2026) Table 23. Global Abortion Medication Sales Volume Share by Type (2027-2032) Table 24. Global Abortion Medication Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Abortion Medication Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Abortion Medication Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Abortion Medication Sales Value Share by Type (2021-2026) Table 28. Global Abortion Medication Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Others Table 32. Global Abortion Medication Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Abortion Medication Sales Volume by Application (2021-2026) & (k units) Table 34. Global Abortion Medication Sales Volume by Application (2027-2032) & (k units) Table 35. Global Abortion Medication Sales Volume Share by Application (2021-2026) Table 36. Global Abortion Medication Sales Volume Share by Application (2027-2032) Table 37. Global Abortion Medication Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Abortion Medication Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Abortion Medication Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Abortion Medication Sales Value Share by Application (2021-2026) Table 41. Global Abortion Medication Sales Value Share by Application (2027-2032) Table 42. Global Abortion Medication Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Abortion Medication Sales by Region (2021-2026) & (k units) Table 44. Global Abortion Medication Sales Market Share by Region (2021-2026) Table 45. Global Abortion Medication Sales by Region (2027-2032) & (k units) Table 46. Global Abortion Medication Sales Market Share by Region (2027-2032) Table 47. Global Abortion Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Abortion Medication Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Abortion Medication Sales Value Share by Region (2021-2026) Table 50. Global Abortion Medication Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Abortion Medication Sales Value Share by Region (2027-2032) Table 52. Global Abortion Medication Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Abortion Medication Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Abortion Medication Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Abortion Medication Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Abortion Medication Sales by Country (2021-2026) & (k units) Table 57. Global Abortion Medication Sales Market Share by Country (2021-2026) Table 58. Global Abortion Medication Sales by Country (2027-2032) & (k units) Table 59. Global Abortion Medication Sales Market Share by Country (2027-2032) Table 60. Global Abortion Medication Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Abortion Medication Sales Value Market Share by Country (2021-2026) Table 62. Global Abortion Medication Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Abortion Medication Sales Value Market Share by Country (2027-2032) Table 64. Cadila Company Information Table 65. Cadila Business Overview Table 66. Cadila Abortion Medication Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Cadila Abortion Medication Product Portfolio Table 68. Cadila Recent Development Table 69. Cipla Company Information Table 70. Cipla Business Overview Table 71. Cipla Abortion Medication Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Cipla Abortion Medication Product Portfolio Table 73. Cipla Recent Development Table 74. Exelgyn Laboratories Company Information Table 75. Exelgyn Laboratories Business Overview Table 76. Exelgyn Laboratories Abortion Medication Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Exelgyn Laboratories Abortion Medication Product Portfolio Table 78. Exelgyn Laboratories Recent Development Table 79. GenBioPro Company Information Table 80. GenBioPro Business Overview Table 81. GenBioPro Abortion Medication Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. GenBioPro Abortion Medication Product Portfolio Table 83. GenBioPro Recent Development Table 84. Zizhu-pharm Company Information Table 85. Zizhu-pharm Business Overview Table 86. Zizhu-pharm Abortion Medication Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Zizhu-pharm Abortion Medication Product Portfolio Table 88. Zizhu-pharm Recent Development Table 89. Shanghai Xinhualian Pharmaceutical Co., Ltd Company Information Table 90. Shanghai Xinhualian Pharmaceutical Co., Ltd Business Overview Table 91. Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Product Portfolio Table 93. Shanghai Xinhualian Pharmaceutical Co., Ltd Recent Development Table 94. Sun Pharma Company Information Table 95. Sun Pharma Business Overview Table 96. Sun Pharma Abortion Medication Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Sun Pharma Abortion Medication Product Portfolio Table 98. Sun Pharma Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Abortion Medication Distributors List Table 102. Abortion Medication Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Abortion Medication Product Image Figure 2. Global Abortion Medication Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Abortion Medication Sales Value (2021-2032) & (US$ Million) Figure 4. Global Abortion Medication Sales (2021-2032) & (k units) Figure 5. Global Abortion Medication Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Abortion Medication Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Mifepristone Image Figure 10. Misoprostol Image Figure 11. Global Abortion Medication Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Abortion Medication Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Abortion Medication Sales Volume Share by Type (2021-2032) Figure 14. Global Abortion Medication Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Abortion Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Abortion Medication Sales Value Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Others Image Figure 20. Global Abortion Medication Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Abortion Medication Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Abortion Medication Sales Volume Share by Application (2021-2032) Figure 23. Global Abortion Medication Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Abortion Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Abortion Medication Sales Value Share by Application (2021-2032) Figure 26. Global Abortion Medication Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Abortion Medication Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Abortion Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Abortion Medication Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Abortion Medication Sales Value (2021-2032) & (US$ Million) Figure 31. North America Abortion Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Abortion Medication Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Abortion Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Abortion Medication Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Abortion Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Abortion Medication Sales Value (2021-2032) & (US$ Million) Figure 37. South America Abortion Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Abortion Medication Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Abortion Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Abortion Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Abortion Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Abortion Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Abortion Medication Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Abortion Medication Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Mifepristone
  • Misoprostol
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Cadila
  • Cipla
  • Exelgyn Laboratories
  • GenBioPro
  • Zizhu-pharm
  • Shanghai Xinhualian Pharmaceutical Co., Ltd
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Abortion Medication Sales Value (2021-2032)
  4. 1.2.2 Global Abortion Medication Sales Volume (2021-2032)
  5. 1.2.3 Global Abortion Medication Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Abortion Medication Market Dynamics
  1. 2.1 Abortion Medication Industry Trends
  2. 2.2 Abortion Medication Industry Drivers
  3. 2.3 Abortion Medication Industry Opportunities and Challenges
  4. 2.4 Abortion Medication Industry Restraints
3 Abortion Medication Market by Company
  1. 3.1 Global Abortion Medication Company Revenue Ranking in 2025
  2. 3.2 Global Abortion Medication Revenue by Company (2021-2026)
  3. 3.3 Global Abortion Medication Sales Volume by Company (2021-2026)
  4. 3.4 Global Abortion Medication Average Price by Company (2021-2026)
  5. 3.5 Global Abortion Medication Company Ranking (2024-2026)
  6. 3.6 Global Abortion Medication Company Manufacturing Base and Headquarters
  7. 3.7 Global Abortion Medication Company Product Type and Application
  8. 3.8 Global Abortion Medication Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Abortion Medication Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Abortion Medication Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Abortion Medication Market by Type
  1. 4.1 Abortion Medication Type Introduction
  2. 4.1.1 Mifepristone
  3. 4.1.2 Misoprostol
  4. 4.2 Global Abortion Medication Sales Volume by Type
  5. 4.2.1 Global Abortion Medication Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Abortion Medication Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Abortion Medication Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Abortion Medication Sales Value by Type
  9. 4.3.1 Global Abortion Medication Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Abortion Medication Sales Value by Type (2021-2032)
  11. 4.3.3 Global Abortion Medication Sales Value Share by Type (2021-2032)
5 Abortion Medication Market by Application
  1. 5.1 Abortion Medication Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Abortion Medication Sales Volume by Application
  6. 5.2.1 Global Abortion Medication Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Abortion Medication Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Abortion Medication Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Abortion Medication Sales Value by Application
  10. 5.3.1 Global Abortion Medication Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Abortion Medication Sales Value by Application (2021-2032)
  12. 5.3.3 Global Abortion Medication Sales Value Share by Application (2021-2032)
6 Abortion Medication Regional Sales and Value Analysis
  1. 6.1 Global Abortion Medication Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Abortion Medication Sales by Region (2021-2032)
  3. 6.2.1 Global Abortion Medication Sales by Region: 2021-2026
  4. 6.2.2 Global Abortion Medication Sales by Region (2027-2032)
  5. 6.3 Global Abortion Medication Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Abortion Medication Sales Value by Region (2021-2032)
  7. 6.4.1 Global Abortion Medication Sales Value by Region: 2021-2026
  8. 6.4.2 Global Abortion Medication Sales Value by Region (2027-2032)
  9. 6.5 Global Abortion Medication Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Abortion Medication Sales Value (2021-2032)
  12. 6.6.2 North America Abortion Medication Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Abortion Medication Sales Value (2021-2032)
  15. 6.7.2 Europe Abortion Medication Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Abortion Medication Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Abortion Medication Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Abortion Medication Sales Value (2021-2032)
  21. 6.9.2 South America Abortion Medication Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Abortion Medication Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Abortion Medication Sales Value Share by Country, 2025 VS 2032
7 Abortion Medication Country-level Sales and Value Analysis
  1. 7.1 Global Abortion Medication Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Abortion Medication Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Abortion Medication Sales by Country (2021-2032)
  4. 7.3.1 Global Abortion Medication Sales by Country (2021-2026)
  5. 7.3.2 Global Abortion Medication Sales by Country (2027-2032)
  6. 7.4 Global Abortion Medication Sales Value by Country (2021-2032)
  7. 7.4.1 Global Abortion Medication Sales Value by Country (2021-2026)
  8. 7.4.2 Global Abortion Medication Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Abortion Medication Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Abortion Medication Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Abortion Medication Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Abortion Medication Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Abortion Medication Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Abortion Medication Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Abortion Medication Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Abortion Medication Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Abortion Medication Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Abortion Medication Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Abortion Medication Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Abortion Medication Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Abortion Medication Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Abortion Medication Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Abortion Medication Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Abortion Medication Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Abortion Medication Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Abortion Medication Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Abortion Medication Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Abortion Medication Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Abortion Medication Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Abortion Medication Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Abortion Medication Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Abortion Medication Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Abortion Medication Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Abortion Medication Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Abortion Medication Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Abortion Medication Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Abortion Medication Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Abortion Medication Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Abortion Medication Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Abortion Medication Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Abortion Medication Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Abortion Medication Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Abortion Medication Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Abortion Medication Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Abortion Medication Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Abortion Medication Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Abortion Medication Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Abortion Medication Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Abortion Medication Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Abortion Medication Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Abortion Medication Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Abortion Medication Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Abortion Medication Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Abortion Medication Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Abortion Medication Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Abortion Medication Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Abortion Medication Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Abortion Medication Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Abortion Medication Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Abortion Medication Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Abortion Medication Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Abortion Medication Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Abortion Medication Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Abortion Medication Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Abortion Medication Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Abortion Medication Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Abortion Medication Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Abortion Medication Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Abortion Medication Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Abortion Medication Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Abortion Medication Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Abortion Medication Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Abortion Medication Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Abortion Medication Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Abortion Medication Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Abortion Medication Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Abortion Medication Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Abortion Medication Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Abortion Medication Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Abortion Medication Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Abortion Medication Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Abortion Medication Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Abortion Medication Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Abortion Medication Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Abortion Medication Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Abortion Medication Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Abortion Medication Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Abortion Medication Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Abortion Medication Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Abortion Medication Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Abortion Medication Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Abortion Medication Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cadila
  2. 8.1.1 Cadila Company Information
  3. 8.1.2 Cadila Business Overview
  4. 8.1.3 Cadila Abortion Medication Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cadila Abortion Medication Product Portfolio
  6. 8.1.5 Cadila Recent Developments
  7. 8.2 Cipla
  8. 8.2.1 Cipla Company Information
  9. 8.2.2 Cipla Business Overview
  10. 8.2.3 Cipla Abortion Medication Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Abortion Medication Product Portfolio
  12. 8.2.5 Cipla Recent Developments
  13. 8.3 Exelgyn Laboratories
  14. 8.3.1 Exelgyn Laboratories Company Information
  15. 8.3.2 Exelgyn Laboratories Business Overview
  16. 8.3.3 Exelgyn Laboratories Abortion Medication Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Exelgyn Laboratories Abortion Medication Product Portfolio
  18. 8.3.5 Exelgyn Laboratories Recent Developments
  19. 8.4 GenBioPro
  20. 8.4.1 GenBioPro Company Information
  21. 8.4.2 GenBioPro Business Overview
  22. 8.4.3 GenBioPro Abortion Medication Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GenBioPro Abortion Medication Product Portfolio
  24. 8.4.5 GenBioPro Recent Developments
  25. 8.5 Zizhu-pharm
  26. 8.5.1 Zizhu-pharm Company Information
  27. 8.5.2 Zizhu-pharm Business Overview
  28. 8.5.3 Zizhu-pharm Abortion Medication Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zizhu-pharm Abortion Medication Product Portfolio
  30. 8.5.5 Zizhu-pharm Recent Developments
  31. 8.6 Shanghai Xinhualian Pharmaceutical Co., Ltd
  32. 8.6.1 Shanghai Xinhualian Pharmaceutical Co., Ltd Company Information
  33. 8.6.2 Shanghai Xinhualian Pharmaceutical Co., Ltd Business Overview
  34. 8.6.3 Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Product Portfolio
  36. 8.6.5 Shanghai Xinhualian Pharmaceutical Co., Ltd Recent Developments
  37. 8.7 Sun Pharma
  38. 8.7.1 Sun Pharma Company Information
  39. 8.7.2 Sun Pharma Business Overview
  40. 8.7.3 Sun Pharma Abortion Medication Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sun Pharma Abortion Medication Product Portfolio
  42. 8.7.5 Sun Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Abortion Medication Value Chain Analysis
  2. 9.1.1 Abortion Medication Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Abortion Medication Sales Mode & Process
  6. 9.2 Abortion Medication Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Abortion Medication Distributors
  9. 9.2.3 Abortion Medication Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst